FR2336139B1 - - Google Patents

Info

Publication number
FR2336139B1
FR2336139B1 FR7637938A FR7637938A FR2336139B1 FR 2336139 B1 FR2336139 B1 FR 2336139B1 FR 7637938 A FR7637938 A FR 7637938A FR 7637938 A FR7637938 A FR 7637938A FR 2336139 B1 FR2336139 B1 FR 2336139B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7637938A
Other languages
French (fr)
Other versions
FR2336139A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2336139A1 publication Critical patent/FR2336139A1/fr
Application granted granted Critical
Publication of FR2336139B1 publication Critical patent/FR2336139B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7637938A 1975-12-23 1976-12-16 Peptide carbazates Granted FR2336139A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/643,721 US4064236A (en) 1975-12-23 1975-12-23 Peptide carbazates and pharmaceutical composition

Publications (2)

Publication Number Publication Date
FR2336139A1 FR2336139A1 (fr) 1977-07-22
FR2336139B1 true FR2336139B1 (US20100154137A1-20100624-C00004.png) 1979-07-13

Family

ID=24582010

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7637938A Granted FR2336139A1 (fr) 1975-12-23 1976-12-16 Peptide carbazates

Country Status (9)

Country Link
US (1) US4064236A (US20100154137A1-20100624-C00004.png)
JP (1) JPS5278829A (US20100154137A1-20100624-C00004.png)
CH (1) CH626050A5 (US20100154137A1-20100624-C00004.png)
DE (1) DE2658254A1 (US20100154137A1-20100624-C00004.png)
DK (1) DK551276A (US20100154137A1-20100624-C00004.png)
FR (1) FR2336139A1 (US20100154137A1-20100624-C00004.png)
GB (1) GB1520830A (US20100154137A1-20100624-C00004.png)
NL (1) NL7613661A (US20100154137A1-20100624-C00004.png)
SE (1) SE7613855L (US20100154137A1-20100624-C00004.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
CS226907B1 (en) * 1981-08-07 1984-04-16 Kasafirek Evzen Alkylamides of carboxyalkanoylpeptides
US5464739A (en) * 1994-08-22 1995-11-07 Bayer Corporation Composition method for determining the presence of leukocyte cells, esterase or protease in a test sample
DE19612644A1 (de) 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
IL155136A0 (en) * 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
AU2004251647B2 (en) 2003-05-29 2010-01-14 Takeda Pharmaceutical Company Limited Abuse resistant amphetamine compounds
EP1776159A1 (en) * 2004-08-09 2007-04-25 Enzymotec Ltd. Food products for diabetics
BRPI0513461A2 (pt) 2004-08-10 2011-05-10 Enzymotec Ltd mÉtodos de tratamento requerendo fito-ingredientes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904593A (en) * 1973-02-07 1975-09-09 American Home Prod Peptide derivatives having an ' -hydrazide linkage and preparation thereof
US3888840A (en) * 1973-02-07 1975-06-10 American Home Prod Novel hydrazinocarboxamide derivatives and preparation thereof

Also Published As

Publication number Publication date
DK551276A (da) 1977-06-24
GB1520830A (en) 1978-08-09
SE7613855L (sv) 1977-06-24
US4064236A (en) 1977-12-20
NL7613661A (nl) 1977-06-27
FR2336139A1 (fr) 1977-07-22
JPS5278829A (en) 1977-07-02
DE2658254A1 (de) 1977-07-07
CH626050A5 (US20100154137A1-20100624-C00004.png) 1981-10-30

Similar Documents

Publication Publication Date Title
JPS5196378A (US20100154137A1-20100624-C00004.png)
FR2336139B1 (US20100154137A1-20100624-C00004.png)
FR2324512B1 (US20100154137A1-20100624-C00004.png)
JPS51161812U (US20100154137A1-20100624-C00004.png)
JPS574811Y2 (US20100154137A1-20100624-C00004.png)
JPS5196963A (US20100154137A1-20100624-C00004.png)
FR2306965B1 (US20100154137A1-20100624-C00004.png)
JPS5543778Y2 (US20100154137A1-20100624-C00004.png)
JPS5420332Y2 (US20100154137A1-20100624-C00004.png)
JPS51129062U (US20100154137A1-20100624-C00004.png)
JPS51152245U (US20100154137A1-20100624-C00004.png)
JPS5193549A (US20100154137A1-20100624-C00004.png)
JPS51117216U (US20100154137A1-20100624-C00004.png)
BG23118A1 (US20100154137A1-20100624-C00004.png)
CH595702A5 (US20100154137A1-20100624-C00004.png)
CH590551A5 (US20100154137A1-20100624-C00004.png)
CH590481A5 (US20100154137A1-20100624-C00004.png)
CH589394A5 (US20100154137A1-20100624-C00004.png)
CH587511B5 (US20100154137A1-20100624-C00004.png)
CH592752A5 (US20100154137A1-20100624-C00004.png)
CH584348A5 (US20100154137A1-20100624-C00004.png)
BG22273A1 (US20100154137A1-20100624-C00004.png)
CH1355175A4 (US20100154137A1-20100624-C00004.png)
CH593567A5 (US20100154137A1-20100624-C00004.png)
CH601205A5 (US20100154137A1-20100624-C00004.png)

Legal Events

Date Code Title Description
ST Notification of lapse